Sign Up to like & get
recommendations!
0
Published in 2017 at "Carbohydrate polymers"
DOI: 10.1016/j.carbpol.2016.12.037
Abstract: Low molecular weight heparins (LMWHs) are produced by chemical or enzymatic depolymerization of unfractionated heparin (UFH). Besides their well-known anticoagulant effects, LMWHs have also been reported to exhibit numerous anti-inflammatory properties. Previous studies have, however,…
read more here.
Keywords:
low molecular;
non anticoagulant;
molecular weight;
weight heparins ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Journal of Pharmaceutical Analysis"
DOI: 10.1016/j.jpha.2021.09.009
Abstract: The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has caused a devastating health crisis worldwide. In this review, we have discussed that prophylactic phytochemical quercetin supplementation in…
read more here.
Keywords:
management covid;
immunomodulatory anticoagulant;
management;
antiviral immunomodulatory ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Journal of Thrombosis and Haemostasis"
DOI: 10.1111/jth.15296
Abstract: Patients with cirrhosis are at risk of venous thromboembolism (VTE), but strategies for thromboprophylaxis have not been defined. Previous in vitro studies suggest an altered anticoagulant effect of heparins in patients with cirrhosis.
read more here.
Keywords:
vivo anticoagulant;
adequate vivo;
cirrhosis;
patients cirrhosis ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Blood"
DOI: 10.1182/blood-2019-131907
Abstract: Introduction/Background: Recombinant coagulation factor Xa (FXa), inactivated Zh-zo, also known as andexanet alfa (AA), is a modified version of human FXa that has been developed as an antidote to neutralize the bleeding effects of oral…
read more here.
Keywords:
rivaroxaban;
time;
betrixaban edoxaban;
neutralization ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Pharmaceuticals"
DOI: 10.3390/ph16030364
Abstract: Higher risk of major hemorrhage associated with concomitant use of dabigatran and simvastatin compared to other statins was previously reported with a suggestion of P-glycoprotein-mediated interaction. The aim of this study was to evaluate the…
read more here.
Keywords:
pharmacokinetics anticoagulant;
dabigatran;
effects dabigatran;
anticoagulant effects ... See more keywords